
iwNHL 2023 Session V: Expanding the CAR platform in NHL
VJHemOnc Podcast
00:00
Comparing CAR T-cell therapies and exploring alternative antigens and off-the-shelf options in cancer treatment
This chapter explores the efficacy of CD-19 targeted CAR T-cells compared to standard chemotherapy and transplant approaches in second-line treatment for cancer. It also discusses the possibility of creating autologous CAR T-cell products targeting different antigens and the potential of allogeneic or off-the-shelf CAR T-cell therapies.
Transcript
Play full episode